Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry
Aim: The aim of the study is to up date informations on the clinical characteristics and outcome of patients with upper-extremity deep vein thrombosis (DVT) from the Informatised Registry on Venous Thromboembolism (RIETE). Methods: RIETE is an ongoing registry of consecutive patients with symptomati...
Збережено в:
Дата: | 2006 |
---|---|
Автори: | , , , , , , |
Формат: | Стаття |
Мова: | English |
Опубліковано: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2006
|
Назва видання: | Experimental Oncology |
Теми: | |
Онлайн доступ: | http://dspace.nbuv.gov.ua/handle/123456789/137569 |
Теги: |
Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
Назва журналу: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
Цитувати: | Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry / M. Monreal, F.J. Munoz, V. Rosa, C. Romero, P. Roman, P. Di Micco, P. Prandoni // Experimental Oncology. — 2006. — Т. 28, № 3. — С. 245-247. — Бібліогр.: 14 назв. — англ. |
Репозитарії
Digital Library of Periodicals of National Academy of Sciences of Ukraineid |
irk-123456789-137569 |
---|---|
record_format |
dspace |
spelling |
irk-123456789-1375692018-06-18T03:06:35Z Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry Monreal, M. Munoz, F.J. Rosa, V. Romero, C. Roman, P. Di Micco, P. Prandoni, P. Short communications Aim: The aim of the study is to up date informations on the clinical characteristics and outcome of patients with upper-extremity deep vein thrombosis (DVT) from the Informatised Registry on Venous Thromboembolism (RIETE). Methods: RIETE is an ongoing registry of consecutive patients with symptomatic, objectively confirmed, acute venous thromboembolism. In this analysis the clinical characteristics and 3-month outcome of all cancer patients with upper-extremity DVT were evaluated. Results: Up to February 2006, a total of 14,391 patients with symptomatic, objectively confirmed acute venous thromboembolism had been enrolled in RIETE. Of the 2,945 patients with active cancer 196 (6.7%) had arm DVT: 104 had catheter-associated DVT. Most cancer patients with arm DVT were males, younger than 65, and had a low incidence of additional risk factors or underlying diseases. Twenty of them (10%) had symptomatic pulmonary embolism (PE). Most patients were treated with low-molecular-weigh heparin, both initially (94%) and after discharge (75%). During the 3-month follow-up period 12 patients (6.1%) developed VTE recurrences (PE 6, DVT 6), 8 (4.1%) had major bleeding (fatal in 3), 43 (22%) died. Conclusions: Our data from the RIETE registry show that upper limb DVT is a serious complication in patients with cancer, with a high incidence of recurrences and bleeding complications. Цель: обновить базу данных по клиническим характеристикам и течению заболевания у больных с тромбозом глубоких вен верхних конечностей (ТГВ) с использованием системы регистра венозного тромбоэмболизма (СРВТ). Методы: СРВТ является непрерывной системой регистрации больных с симптомами объективно подтвержденной острой венозной тромбоэмболии. Проанализированы клинические характеристики и течение болезни на протяжении месяцев у больных онкологического профиля с ТГВ. Результаты: в период декабря 2006 г. были обследованы 14 391 больных с симптоматической объективно подтвержденной острой венозной тромбоэмболией при помощи системы СРВТ. Из 2945 больных с прогрессирующим течением заболевания у196 (6,7%) человек выявили ТГВ верхних конечностей: у 104 — ассоциированный с катетером ТГВ. Большинство больных с ТГВ верхних конечностей — лица мужского пола в возрасте моложе 65 лет и с низкой частотой дополнительных факторов риска или первичного заболевания. У 20 из них (10%) отмечали симптомы эмболии легочной артерии (ЭЛА). Больные получали низкомолекулярный гепарин и в начале исследования (94%), и по его окончании (75%). В течение последующих трех месяцев у12 больных (6,1%) развился рецидив венозной тромбоэмболии (ВТЭ) (ЭЛА – у 6 больных, ТГВ – у 6 больных), у 8 (4,1%) отмечали кровотечение (3 случая с летальным исходом), 43 (22%) пациента умерли. Выводы: данные СРВТ системы показали, что ТГВ верхних конечностей является серьезным осложнением у больных, онкологического профиля, сочетающимся с высокой степенью развития рецидива и осложнений, сопровождающихся кровотечениями. 2006 Article Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry / M. Monreal, F.J. Munoz, V. Rosa, C. Romero, P. Roman, P. Di Micco, P. Prandoni // Experimental Oncology. — 2006. — Т. 28, № 3. — С. 245-247. — Бібліогр.: 14 назв. — англ. 1812-9269 http://dspace.nbuv.gov.ua/handle/123456789/137569 en Experimental Oncology Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
institution |
Digital Library of Periodicals of National Academy of Sciences of Ukraine |
collection |
DSpace DC |
language |
English |
topic |
Short communications Short communications |
spellingShingle |
Short communications Short communications Monreal, M. Munoz, F.J. Rosa, V. Romero, C. Roman, P. Di Micco, P. Prandoni, P. Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry Experimental Oncology |
description |
Aim: The aim of the study is to up date informations on the clinical characteristics and outcome of patients with upper-extremity deep vein thrombosis (DVT) from the Informatised Registry on Venous Thromboembolism (RIETE). Methods: RIETE is an ongoing registry of consecutive patients with symptomatic, objectively confirmed, acute venous thromboembolism. In this analysis the clinical characteristics and 3-month outcome of all cancer patients with upper-extremity DVT were evaluated. Results: Up to February 2006, a total of 14,391 patients with symptomatic, objectively confirmed acute venous thromboembolism had been enrolled in RIETE. Of the 2,945 patients with active cancer 196 (6.7%) had arm DVT: 104 had catheter-associated DVT. Most cancer patients with arm DVT were males, younger than 65, and had a low incidence of additional risk factors or underlying diseases. Twenty of them (10%) had symptomatic pulmonary embolism (PE). Most patients were treated with low-molecular-weigh heparin, both initially (94%) and after discharge (75%). During the 3-month follow-up period 12 patients (6.1%) developed VTE recurrences (PE 6, DVT 6), 8 (4.1%) had major bleeding (fatal in 3), 43 (22%) died. Conclusions: Our data from the RIETE registry show that upper limb DVT is a serious complication in patients with cancer, with a high incidence of recurrences and bleeding complications. |
format |
Article |
author |
Monreal, M. Munoz, F.J. Rosa, V. Romero, C. Roman, P. Di Micco, P. Prandoni, P. |
author_facet |
Monreal, M. Munoz, F.J. Rosa, V. Romero, C. Roman, P. Di Micco, P. Prandoni, P. |
author_sort |
Monreal, M. |
title |
Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry |
title_short |
Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry |
title_full |
Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry |
title_fullStr |
Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry |
title_full_unstemmed |
Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry |
title_sort |
upper extremity dvt in oncological patients: analysis of risk factors. data from the riete registry |
publisher |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України |
publishDate |
2006 |
topic_facet |
Short communications |
url |
http://dspace.nbuv.gov.ua/handle/123456789/137569 |
citation_txt |
Upper extremity dvt in oncological patients: analysis of risk factors. Data from the RIETE registry / M. Monreal, F.J. Munoz, V. Rosa, C. Romero, P. Roman, P. Di Micco, P. Prandoni // Experimental Oncology. — 2006. — Т. 28, № 3. — С. 245-247. — Бібліогр.: 14 назв. — англ. |
series |
Experimental Oncology |
work_keys_str_mv |
AT monrealm upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry AT munozfj upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry AT rosav upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry AT romeroc upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry AT romanp upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry AT dimiccop upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry AT prandonip upperextremitydvtinoncologicalpatientsanalysisofriskfactorsdatafromtherieteregistry |
first_indexed |
2023-10-18T21:14:46Z |
last_indexed |
2023-10-18T21:14:46Z |
_version_ |
1796152310711189504 |